Dry Mouth and Dental Health on GLP-1s: Sorting "Ozempic Teeth" Evidence From Hype

"Ozempic teeth" is a social-media label, not a diagnosis. The FDA labels for the major GLP-1 drugs don't list tooth decay or gum disease as adverse reactions, and the research so far doesn't show these drugs damage teeth directly. What is plausible is an indirect path: people on GLP-1s often drink less, some develop dry mouth, and vomiting and reflux expose teeth to stomach acid. Those are real dental risk factors, and they're manageable.

Here's what's documented, what's speculative, and what you can do about it.

What the labels say

We reviewed the current prescribing information for Wegovy, Ozempic, Zepbound, and Mounjaro. None lists dental caries, periodontitis, or tooth loss among adverse reactions.

The Zepbound label is the only one of the four that lists dry mouth in the sections we reviewed: dry mouth or dry throat in 1% of patients on tirzepatide vs. 0.1% on placebo. That's a real but small difference.

What the labels do document are the GI effects that can matter for teeth:

On Zepbound, vomiting ranged from 8% to 13% by dose vs. 2% on placebo, and GERD from 4% to 5% vs. 2%.

Where the "Ozempic teeth" idea comes from

The term spread through news coverage and patient anecdotes describing dry mouth, bad breath, gum inflammation, and cavities. ADA News, the American Dental Association's news service, has covered the trend and attributes the reported problems mainly to dry mouth and dehydration, linked to reduced appetite and thirst, with vomiting adding to the risk.

The best-known academic review so far comes from Aviv Ouanounou, an associate professor at the University of Toronto's Faculty of Dentistry, and dental student Karina Kofman, published in the Canadian Journal of Diabetes. According to the university's summary, the authors noted that the existing literature is mostly case reports, that controlled studies are still needed, and that there are no consensus guidelines from oral health organizations yet. Ouanounou is quoted saying, "We need to be evidence-based."

The newest data point: a large preprint

In August 2026, researchers at the health-data company nference posted a preprint comparing oral health outcomes in 184,582 adults on semaglutide or tirzepatide with people on other diabetes therapies, over 12 months. As reported by DentistryIQ:

• 8.69% of GLP-1 users had at least one newly documented oral condition.
• Dry mouth was the most common, at 5.29%, and was more frequent with greater weight loss.
• GLP-1 users had a lower relative risk of new dental caries (0.47) and periodontitis (about 0.50) than the comparison group.
• Dental calculus (tartar) was the only condition significantly more common in GLP-1 users.

This hasn't been peer reviewed, and it shows associations, not cause and effect. The authors themselves said the data don't prove GLP-1s protect against oral disease. A fair reading is that, at the population level, there's no sign so far that these drugs drive a wave of cavities or gum disease, while dry mouth looks like the effect most worth watching.

Why dry mouth matters for your teeth

Saliva does a lot of quiet work. The NIH's National Institute of Dental and Craniofacial Research explains that saliva washes away food particles, contains calcium and phosphate that help keep teeth strong, and keeps harmful germs in check. With less saliva, the risk of tooth decay and fungal mouth infections goes up.

NIDCR lists these dry mouth symptoms:

• A sticky, dry feeling in the mouth
• Trouble chewing, swallowing, tasting, or speaking
• A burning feeling in the mouth or a dry throat
• Cracked lips or a dry, rough tongue
• Mouth sores, frequent mouth infections, or bad breath

Many medications cause dry mouth, including some blood pressure medicines and antidepressants, so if you take several, the effects can stack. Dehydration from GI side effects adds to it. Our post on when low intake becomes a clinical issue covers fluid risks more broadly.

Who may be at higher risk

Nobody has published a validated risk score for dental problems on GLP-1s. Based on the known risk factors for dry mouth and enamel erosion, these groups have the most reason to be proactive:

• People with frequent vomiting or reflux, especially during dose escalation, when the Wegovy label says most GI reactions occurred.
• People taking other mouth-drying medications. NIDCR names some blood pressure, depression, and bladder-control medicines among the hundreds of drugs that reduce saliva.
• People with diabetes, which NIDCR also lists as a cause of dry mouth, and which on its own is linked to gum disease.
• People losing weight quickly. In the 2026 preprint, dry mouth was more common with greater weight loss.
• People with existing dental work or a history of cavities, since less saliva means less natural protection at the margins of fillings and crowns.
• People who've shifted to grazing on simple carbohydrates because larger meals no longer feel comfortable.

If you fit several of these, it's worth booking a dental checkup early in treatment rather than waiting for a problem. A dentist can set a baseline, look for early erosion, and recommend fluoride products or a cleaning schedule that fits your situation.

What isn't supported

Claims that GLP-1s "dissolve" teeth, cause teeth to fall out, or damage the jawbone aren't backed by the labels or the research we reviewed. If you see dramatic before-and-after photos, keep in mind they can't show what caused the change or what the person's mouth looked like before treatment.

How to protect your teeth

1. Drink water through the day. NIDCR recommends sipping water or sugarless drinks, especially with meals. Thirst may be muted on a GLP-1, so keep a bottle in view.
2. Stimulate saliva. Sugarless gum or hard candy helps. NIDCR notes some contain xylitol, which may help prevent cavities. Go easy if sugar alcohols upset your stomach.
3. Limit mouth-drying habits. NIDCR advises limiting caffeine and avoiding tobacco and alcohol. A bedroom humidifier can help at night.
4. After vomiting, rinse, then wait. The Toronto review recommends rinsing after vomiting and waiting at least 30 minutes before brushing, since enamel is softened by acid.
5. Manage reflux. Smaller meals and not lying down after eating help. See our GERD guide.
6. Keep up with cleanings and tell your dentist. ADA News advises telling both your dentist and doctor that you take a GLP-1. The Toronto review suggests dentists consider more frequent cleanings, as often as every three months, for patients with dry mouth.
7. Watch sugar in "easy" foods. When appetite is low, people often graze on crackers, juice, or sweets. Frequent sugar exposure with less saliva is a cavity setup.

If dry mouth persists, a dentist or doctor can look at your medication list, recommend saliva substitutes, or, in some cases, prescribe medication, per NIDCR. Mention your GLP-1 if you need oral surgery or sedation too. The labels note rare reports of aspiration under deep sedation in people on these drugs. See what to tell the care team before a procedure.

When to see a dentist or doctor

Contact your prescriber if:

• You're vomiting often enough to worry about your teeth. That's also a dehydration and kidney concern.
• Dry mouth comes with extreme thirst, peeing less, or dizziness, which can signal dehydration.
• Reflux is frequent, especially at night.

What to tell your dentist

• Which GLP-1 you take, the dose, and when you started.
• Whether you have frequent vomiting, reflux, or belching.
• Your other medications, especially any that cause dry mouth.
• Any changes in eating patterns, like grazing or more sugary drinks.
• Upcoming procedures with sedation, so the dental team can coordinate with your prescriber.

For a related mouth-and-breath complaint, see our sulfur burps guide, and for other claims that circulate online, our GLP-1 myths evidence review.